Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire
- PMID: 16875787
- DOI: 10.1016/j.addbeh.2006.06.028
Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire
Abstract
We examined the validity and reliability of the modified Cigarette Evaluation Questionnaire (mCEQ) that assesses the degree to which subjects experience the reinforcing effects of smoking. Data came from three phase II clinical trials (n=626, n=627, n=312) on varenicline for smoking cessation. Comparative fit indexes and non-normed fit indexes from a confirmatory factor analysis exceeded 0.90. Cronbach's alpha for internal consistency reliability exceeded 0.70 for the Smoking Satisfaction domain and the Psychological Reward domain but was less than 0.70 for the Aversion domain; test-retest reliability generally exceeded 0.70 on the three multi-item domains and two single items. The validity and, in general, the reliability of the postulated multidimensional framework of the mCEQ are confirmed and supported by the analyses of three independent studies, with multi-item domains on Smoking Satisfaction (satisfying, taste good, enjoy smoking), Psychological Reward (calm down, more awake, less irritable, help concentrate, reduce hunger), and Aversion (dizziness, nauseous), as well as the single-item assessment on Enjoyment of Respiratory Tract Sensations and on Craving Reduction.
Similar articles
-
Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale.Curr Med Res Opin. 2005 May;21(5):749-60. doi: 10.1185/030079905X43712. Curr Med Res Opin. 2005. PMID: 15969874
-
Preliminary validity of the modified Cigarette Evaluation Questionnaire in predicting the reinforcing effects of cigarettes that vary in nicotine content.Exp Clin Psychopharmacol. 2017 Dec;25(6):473-478. doi: 10.1037/pha0000145. Exp Clin Psychopharmacol. 2017. PMID: 29251976 Free PMC article. Clinical Trial.
-
Evaluation of the Chinese versions of the Minnesota nicotine withdrawal scale and the questionnaire on smoking urges-brief.Nicotine Tob Res. 2010 Jun;12(6):630-4. doi: 10.1093/ntr/ntq063. Epub 2010 May 24. Nicotine Tob Res. 2010. PMID: 20498226
-
Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.Cardiol Rev. 2007 May-Jun;15(3):154-61. doi: 10.1097/01.crd.0000260270.12829.45. Cardiol Rev. 2007. PMID: 17438382 Review.
-
Practical implementation of varenicline as an aid to smoking cessation in clinical practice.Pneumologia. 2009 Jul-Sep;58(3):167-74. Pneumologia. 2009. PMID: 19817313 Review.
Cited by
-
Dose-response effects of spectrum research cigarettes.Nicotine Tob Res. 2013 Jun;15(6):1113-21. doi: 10.1093/ntr/nts247. Epub 2012 Nov 22. Nicotine Tob Res. 2013. PMID: 23178320 Free PMC article. Clinical Trial.
-
Anxiety sensitivity as a predictor of acute subjective effects of smoking.Nicotine Tob Res. 2013 Jun;15(6):1084-90. doi: 10.1093/ntr/nts208. Epub 2012 Nov 9. Nicotine Tob Res. 2013. PMID: 23144083 Free PMC article.
-
Real-world exposure to graphic warning labels on cigarette packages in US smokers: The CASA randomized trial protocol.Contemp Clin Trials. 2020 Nov;98:106152. doi: 10.1016/j.cct.2020.106152. Epub 2020 Sep 20. Contemp Clin Trials. 2020. PMID: 32966877 Free PMC article.
-
The Impact of E-liquid Propylene Glycol and Vegetable Glycerin Ratio on Ratings of Subjective Effects, Reinforcement Value, and Use in Current Smokers.Nicotine Tob Res. 2020 Apr 21;22(5):791-797. doi: 10.1093/ntr/ntz130. Nicotine Tob Res. 2020. PMID: 31403695 Free PMC article. Clinical Trial.
-
Menthol versus non-menthol flavouring and switching to e-cigarettes in black and Latinx adult menthol combustible cigarette smokers: secondary analyses from a randomised clinical trial.Tob Control. 2023 Nov;32(6):786-789. doi: 10.1136/tobaccocontrol-2021-057180. Epub 2022 Mar 29. Tob Control. 2023. PMID: 35351805 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical